Perspective Technologies of Vaccination and Immunotherapy
Deadline for manuscript submissions: closed (10 March 2021) | Viewed by 34992
2. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Interests: human immunodeficiency virus type 1; human hepatitis C virus; DNA vaccines; in vivo imaging; T cell response; B cell response; mouse models; cancer; oxidative stress
Special Issues, Collections and Topics in MDPI journals
2. Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa
Interests: virology; immunology; viral haemorrhagic fevers and arboviruses
We are pleased to introduce the 4th International on-line Conference devoted to vaccines, vaccination and immunotherapy “Perspective technologies of vaccination and immunotherapy” October 27-29, 2020 (www.techvac.org).
This conference was organized and supported by the Chumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products of Russian Academy of Sciences, Moscow, Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, St Petersburg, and International Society for Vaccines (ww.isv.org).
First held in November 2016, this series of vaccine conferences bring together specialists from all over the world including researchers, both advanced and early carrier investigators, healthcare professionals, government officials, and industry representatives from the many disciplines of vaccinology field.
TECHVAC conferences cover all fields related to vaccines and vaccination, new vaccines, new vaccination strategies, techniques and policies, vaccine-specific issues (including polio, measles, meningococcal & pneumococcal diseases, influenza, HIV and AIDS, HPV, flaviviruses), ethical issues related to vaccine trials, finances and communication. This year, special section was devoted to SARS-CoV-2 pandemics and development of COVID-19 vaccines.
Conferences feature invited lectures by world-renowned vaccinology experts, peer-reviewed submitted oral abstracts and posters, panel discussions, scientific awards, and networking events to create a rich environment stimulating engagement and collaboration.
Program and Organizing Committees of TECHVAC2020 conference together with the Board of the International Society for Vaccines is preparing a communique on the urgent needs and deeds of the vaccinology today addressing broad audience of researchers, vaccine developers and health care professionals, which will be published in the conference web.
Program of the conference held on line October 27-29, 2020 can be viewed at the link http://techvac.org/programme/conference-programme/ . Conference was attended by 74 registered participants from 9 countries. It was organized in eight sessions with the total of 39 oral and 9 poster presentations. All materials, abstracts and photogallery will be available at www.techvac.org by the end of November 2020.
Recordings of the presentations are available to the registered participants.
Expert Review of the Presented Studies
Content of the presented studies was evaluated by the committee of five independent experts. Based on their scores, 16 studies were suggested for submission as manuscripts to this Vaccines issue, including 9 studies from the research institutes in Moscow, St Petersburg and Novosibirsk in Russia, and 7 studies from USA, Italy, France, Sweden, China and Latvia.
The Expert Committee of The International Conference "Perspective technologies of vaccination and immunotherapy" TECHVAC2020 held on-line October 27-29, 2020 has selected for Young Researcher Awards the following studies presented on the conference:
First prize - 300 euro
to the study by Olga Trofimova (Latvian Biomedical Research and Study Center, Riga, Latvia) "Alphavirus-driven IFN-gamma: intratumoral expression promotes macrophage polarization to M1 phenotype with further tumour growth inhibition" (oral)
Second prize - 200 euro
to the study by Thomas Tipih (University of the Free State, Bloemfontein, South Africa) "Sindbis virus replicon DNA vector expressing Crimean-Congo hemmorhagic fever virus nucleoprotein antigen induces humoral and cell mediated immune responses in mice" (oral)
Third prize - 100 euro
to the study by Starostina Ekaterina (State Research Center of Virology and Biotechnology Vector, Koltzovo, Novosibirsk Region, Russia) "Immunogenicity of DNA vaccines carrying artificial genes encoding fragments of influenza A virus hemagglutinin stem and M2 protein" (oral)
Best poster presentation - 100 euro
to the study by Tatiana Ozharovskaia (N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Moscow, Russia) "Immunogenicity and protective activity of recombinant adenoviruses type 5, expressing different forms of MERS coronavirus S protein"
Expert Committee of TECHVAC2020 conference has given special award for young researchers "Prize for Excellence" to Dr Inna Dolzhikova (Gamaleya National Research Center for Epidemiology and Microbiology, Moscow, Russia) for the oral presentation "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomized phase 1/2 studies from Russia"
Winners of the awards for oral presentations can submit manuscripts describing these studies to the special issue of VACCINES. Studies should be presented in full, including the complementing data obtained before and/or after the conference presentation and not presented on the meeting, if so requested by the Expert Committee of TECHVAC2020. If accepted, these manuscripts will be published free of charge (Sponsored by Vaccines).
Dr. Maria Isaguliants
Prof. Dr. Felicity Jane Burt
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- new vaccines
- new vaccination strategies, techniques and policies
- vaccine-specific issues
- meningococcal & pneumococcal diseases
- HIV and AIDS
- ethical issues related to vaccine trials, finances and communication